Evidence map›Paper›PMID 33139716›Full record

ArticleNature communications2020

Allomorphy as a mechanism of post-translational control of enzyme activity.

Henry P Wood, F Aaron Cruz-Navarrete, Nicola J Baxter, Clare R Trevitt, Angus J Robertson, Samuel R Dix, Andrea M Hounslow, Matthew J Cliff, Jonathan P Waltho

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Henry P WoodKrebs Institute for Biomolecular Research, Department of Molecular Biology and Biotechnology, The University of Sheffield, Sheffield, S10 2TN, UK.
F Aaron Cruz-NavarreteKrebs Institute for Biomolecular Research, Department of Molecular Biology and Biotechnology, The University of Sheffield, Sheffield, S10 2TN, UK. facruznavarrete1@sheffield.ac.uk.ORCID 0000-0002-5233-581X
Nicola J BaxterKrebs Institute for Biomolecular Research, Department of Molecular Biology and Biotechnology, The University of Sheffield, Sheffield, S10 2TN, UK.
Clare R TrevittKrebs Institute for Biomolecular Research, Department of Molecular Biology and Biotechnology, The University of Sheffield, Sheffield, S10 2TN, UK.
Angus J RobertsonKrebs Institute for Biomolecular Research, Department of Molecular Biology and Biotechnology, The University of Sheffield, Sheffield, S10 2TN, UK.
Samuel R DixKrebs Institute for Biomolecular Research, Department of Molecular Biology and Biotechnology, The University of Sheffield, Sheffield, S10 2TN, UK.ORCID 0000-0002-6907-1435
Andrea M HounslowKrebs Institute for Biomolecular Research, Department of Molecular Biology and Biotechnology, The University of Sheffield, Sheffield, S10 2TN, UK.
Matthew J CliffManchester Institute of Biotechnology and School of Chemistry, The University of Manchester, Manchester, M1 7DN, UK.ORCID 0000-0002-7482-0234
Jonathan P WalthoKrebs Institute for Biomolecular Research, Department of Molecular Biology and Biotechnology, The University of Sheffield, Sheffield, S10 2TN, UK. j.waltho@sheffield.ac.uk.ORCID 0000-0002-7402-5492
University of Sheffield · GBUniversity of Manchester · GBNational Institutes of Health · US

Funding

Biotechnology and Biological Sciences Research Council BB/M021637/1Biotechnology and Biological Sciences Research Council BB/P007066/1Biotechnology and Biological Sciences Research Council BB/R000727/1Biotechnology and Biological Sciences Research Council BB/S007965/1Biotechnology and Biological Sciences Research Council X/009906-20-26Medical Research Council MC_U117533887
6 · The paper itself

Abstract

Enzyme regulation is vital for metabolic adaptability in living systems. Fine control of enzyme activity is often delivered through post-translational mechanisms, such as allostery or allokairy. β-phosphoglucomutase (βPGM) from Lactococcus lactis is a phosphoryl transfer enzyme required for complete catabolism of trehalose and maltose, through the isomerisation of β-glucose 1-phosphate to glucose 6-phosphate via β-glucose 1,6-bisphosphate. Surprisingly for a gatekeeper of glycolysis, no fine control mechanism of βPGM has yet been reported. Herein, we describe allomorphy, a post-translational control mechanism of enzyme activity. In βPGM, isomerisation of the K145-P146 peptide bond results in the population of two conformers that have different activities owing to repositioning of the K145 sidechain. In vivo phosphorylating agents, such as fructose 1,6-bisphosphate, generate phosphorylated forms of both conformers, leading to a lag phase in activity until the more active phosphorylated conformer dominates. In contrast, the reaction intermediate β-glucose 1,6-bisphosphate, whose concentration depends on the β-glucose 1-phosphate concentration, couples the conformational switch and the phosphorylation step, resulting in the rapid generation of the more active phosphorylated conformer. In enabling different behaviours for different allomorphic activators, allomorphy allows an organism to maximise its responsiveness to environmental changes while minimising the diversion of valuable metabolites.

Indexed as

Protein Processing, Post-TranslationalAllosteric RegulationAllosteric SiteCrystallography, X-RayEnzyme AssaysGlucose-6-PhosphateGlucosephosphatesGlycolysisIsomerismKineticsMolecular ConformationPhosphorylationPhosphotransferases (Phosphomutases)ProlineProtein DomainsProton Magnetic Resonance Spectroscopybeta-phosphoglucomutase, Lactococcus lactisglucose-1,6-bisphosphateglucose-1-phosphateGlucose-6-PhosphateGlucosephosphatesPhosphotransferases (Phosphomutases)ProlineRecombinant Proteins

Identifiers

PMID33139716
PMCPMC7608592
OpenAlexW3097879644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.